Julie Marker

1.4k total citations
35 papers, 569 citations indexed

About

Julie Marker is a scholar working on Oncology, Public Health, Environmental and Occupational Health and General Health Professions. According to data from OpenAlex, Julie Marker has authored 35 papers receiving a total of 569 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Oncology, 11 papers in Public Health, Environmental and Occupational Health and 10 papers in General Health Professions. Recurrent topics in Julie Marker's work include Cardiac Health and Mental Health (6 papers), Patient-Provider Communication in Healthcare (5 papers) and Palliative Care and End-of-Life Issues (4 papers). Julie Marker is often cited by papers focused on Cardiac Health and Mental Health (6 papers), Patient-Provider Communication in Healthcare (5 papers) and Palliative Care and End-of-Life Issues (4 papers). Julie Marker collaborates with scholars based in Australia, United States and United Kingdom. Julie Marker's co-authors include Frida Cheok, Lani Zimmerman, G. C. Scroop, Nadia Corsini, Amanda D. Hutchinson, Marion Eckert, Imogen Ramsey, David Banham, G. Schrader and Michael L. Roberts and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and American Heart Journal.

In The Last Decade

Julie Marker

34 papers receiving 540 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Julie Marker Australia	13	149	145	109	95	67	35	569
Marjolein H. Kamphuis Netherlands	11	77 0.5×	197 1.4×	80 0.7×	109 1.1×	93 1.4×	12	756
Béatrice Trombert France	15	113 0.8×	51 0.4×	64 0.6×	94 1.0×	70 1.0×	55	756
Zeba M. Khan United States	15	54 0.4×	111 0.8×	114 1.0×	84 0.9×	86 1.3×	49	897
Chiara Marzorati Italy	14	228 1.5×	98 0.7×	115 1.1×	28 0.3×	111 1.7×	48	689
Catherine Paton United Kingdom	10	50 0.3×	302 2.1×	174 1.6×	59 0.6×	124 1.9×	21	1.0k
Homa Keshavarz Canada	13	155 1.0×	53 0.4×	59 0.5×	42 0.4×	110 1.6×	25	551
Dounya Schoormans Netherlands	16	316 2.1×	171 1.2×	68 0.6×	46 0.5×	72 1.1×	47	765
Elsa Vitale Italy	15	70 0.5×	125 0.9×	156 1.4×	31 0.3×	56 0.8×	141	783
Julie A. Murphy United States	14	38 0.3×	54 0.4×	76 0.7×	86 0.9×	87 1.3×	44	507
Nathaniel S. O’Connell United States	10	78 0.5×	45 0.3×	121 1.1×	41 0.4×	111 1.7×	50	598

Countries citing papers authored by Julie Marker

Since Specialization

Citations

This map shows the geographic impact of Julie Marker's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Julie Marker with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Julie Marker more than expected).

Fields of papers citing papers by Julie Marker

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Julie Marker. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Julie Marker. The network helps show where Julie Marker may publish in the future.

Co-authorship network of co-authors of Julie Marker

This figure shows the co-authorship network connecting the top 25 collaborators of Julie Marker. A scholar is included among the top collaborators of Julie Marker based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Julie Marker. Julie Marker is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Bowen, Joanne M., Scott D. Smid, Sepehr Shakib, et al.. (2025). Medicinal CANnabis (CBD/THC) to prevent the symptoms and side effects of chemotherapy in people with advanced CANcer (CANCAN): protocol for a phase II, randomised, double-blind, placebo-controlled trial. BMJ Open. 15(3). e089336–e089336. 2 indexed citations

Kim, Bora, Kate White, Julie Marker, et al.. (2024). Experiences and perspectives of colorectal cancer survivors and general practitioners on the delivery of survivorship care in general practice: a mixed methods study. Australian Journal of Primary Health. 30(2).

Sharp, Rebecca, Qunyan Xu, Nadia Corsini, et al.. (2024). Supportive care needs of adults living with a peripherally inserted central catheter (PICC) at home: a qualitative content analysis. BMC Nursing. 23(1). 4–4. 5 indexed citations

McIntosh, Jennifer, Finlay Macrae, Patty Chondros, et al.. (2024). Should I Take Aspirin? (SITA): randomised controlled trial of a decision aid for cancer chemoprevention. British Journal of General Practice. 74(745). e498–e507. 1 indexed citations

Sharp, Rebecca, Qunyan Xu, Nadia Corsini, et al.. (2023). Community-based Intravenous Treatment and Central Venous Access Devices: A Scoping Review of the Consumer and Caregiver Experience, Information Preferences, and Supportive Care Needs. Journal of Community Health Nursing. 40(1). 28–51. 1 indexed citations

Jefford, Michael, Jon Emery, Andrew Martin, et al.. (2023). SCORE: A multisite randomised controlled trial evaluating shared care for colorectal cancer survivors.. Journal of Clinical Oncology. 41(16_suppl). 1505–1505. 1 indexed citations

Jefford, Michael, Jon Emery, Andrew Martin, et al.. (2023). SCORE: a randomised controlled trial evaluating shared care (general practitioner and oncologist) follow-up compared to usual oncologist follow-up for survivors of colorectal cancer. EClinicalMedicine. 66. 102346–102346. 4 indexed citations

Ramsey, Imogen, Nadia Corsini, Amanda D. Hutchinson, Julie Marker, & Marion Eckert. (2022). Challenges and opportunities for using population health data to investigate cancer survivors’ quality of life in Australia. Quality of Life Research. 31(10). 2977–2983. 6 indexed citations

Bergin, Rebecca J., Camille E. Short, Julie Marker, et al.. (2022). The nature and impact of patient and public involvement in cancer prevention, screening and early detection research: A systematic review. Preventive Medicine. 167. 107412–107412. 12 indexed citations

10.

Ramsey, Imogen, Nadia Corsini, Amanda D. Hutchinson, Julie Marker, & Marion Eckert. (2020). A core set of patient-reported outcomes for population-based cancer survivorship research: a consensus study. Journal of Cancer Survivorship. 15(2). 201–212. 28 indexed citations

11.

Ramsey, Imogen, Marion Eckert, Amanda D. Hutchinson, Julie Marker, & Nadia Corsini. (2020). Core outcome sets in cancer and their approaches to identifying and selecting patient-reported outcome measures: a systematic review. Journal of Patient-Reported Outcomes. 4(1). 77–77. 33 indexed citations

12.

Ramsey, Imogen, Nadia Corsini, Amanda D. Hutchinson, Julie Marker, & Marion Eckert. (2019). Development of a Core Set of Patient-Reported Outcomes for Population-Based Cancer Survivorship Research: Protocol for an Australian Consensus Study. JMIR Research Protocols. 9(1). e14544–e14544. 4 indexed citations

13.

Laaksonen, Maarit A., Karen Canfell, Robert J. MacInnis, et al.. (2018). A Large Linked Study to Evaluate the Future Burden of Cancer in Australia Attributable to Current Modifiable Behaviours. International Journal for Population Data Science. 3(4). 1 indexed citations

14.

Zannettino, Lana, et al.. (2016). Raising the awareness of undergraduate nurses to the psychosocial impact of living with cancer: A consumer engagement in teaching initiative. Asia-Pacific Journal of Oncology Nursing. 3(2). 121–124. 4 indexed citations

15.

Roberts‐Thomson, Ian C., et al.. (2008). Single-center study comparing computed tomography colonography with conventional colonoscopy. World Journal of Gastroenterology. 14(3). 469–469. 15 indexed citations

16.

Wade, Victoria, et al.. (2005). Depression after cardiac hospitalisation--the Identifying Depression as a Comorbid Condition (IDACC) study.. PubMed. 34(11). 985–9. 11 indexed citations

17.

Cheok, Frida, et al.. (2003). Identification, course, and treatment of depression after admission for a cardiac condition: rationale and patient characteristics for the identifying depression as a comorbid condition (IDACC) project. American Heart Journal. 146(6). 978–984. 60 indexed citations

18.

Gore, C. J., G. C. Scroop, Julie Marker, & Peter Catcheside. (1992). Plasma volume, osmolarity, total protein and electrolytes during treadmill running and cycle ergometer exercise. European Journal of Applied Physiology. 65(4). 302–310. 29 indexed citations

19.

Marker, Julie & Michael L. Roberts. (1988). Chronotropic actions of cholecystokinin octapeptide on the rat heart. Regulatory Peptides. 20(3). 251–259. 20 indexed citations

20.

Marker, Julie, Timothy S. Miles, & G. C. Scroop. (1980). Modulation of the Baroreceptor Reflex by Angiotensin II and other Vasoactive Drugs in Anaesthetized Greyhounds. Clinical Science. 58(1). 7–13. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact